SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Pharm Country
TG Therapeutics to Present Results from the ULTIMATE I & II Phase 3 Trials Evaluating Ublituximab in Multiple Sclerosis at the Upcoming American Academy of Neurology 73rd Annual Meeting
March 4, 2021
 · 
6 min read
Pharm Country
TG Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
March 4, 2021
 · 
1 min read
Business
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial ResultsConference call to be held today, Tuesday, March 2, 2021 at 8:30 AM ET
March 2, 2021
 · 
12 min read
Business
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2020 Financial Results and Business UpdateConference call to be held Tuesday, March 2, 2021 at 8:30 AM ET
February 26, 2021
 · 
1 min read
Pharm Country
TG Therapeutics Announces Publication of Final Results from the Phase 3 GENUINE Trial Evaluating Ublituximab Plus Ibrutinib in Patients with Relapsed/Refractory High-Risk Chronic Lymphocytic Leukemia in The Lancet Haematology
February 23, 2021
 · 
6 min read
FDA
FDA Action Alert: G1, TG and Bristol Myers Squibb and Exelixis
February 12, 2021
 · 
6 min read
 · 
Mark Terry
Policy
Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL
February 8, 2021
 · 
5 min read
FDA
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)
February 5, 2021
 · 
16 min read
Pharm Country
TG Therapeutics to Participate in the B. Riley Securities Oncology Investor ConferenceFireside chat scheduled for Wednesday, January 20, 2021 at 10:00 AM ET
January 15, 2021
 · 
1 min read
Pharm Country
TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Tuesday, January 12, 2021 at 2:00 PM ET
January 8, 2021
 · 
1 min read
BioMidwest
Biopharma Money on the Move: December 16-22
December 23, 2020
 · 
4 min read
 · 
Kate Goodwin
Deals
TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock - Dec 15, 2020
December 14, 2020
 · 
5 min read
Pharm Country
TG Therapeutics Announces Proposed Public Offering of Common Stock
December 14, 2020
 · 
5 min read
Ublituximab shows better results than Aubagio in p
Drug Development
TG’s New Drug Ublituximab Outshines Sanofi’s Aubagio in MS Phase III Trial
December 10, 2020
 · 
3 min read
 · 
Mark Terry
Drug Development
TG Therapeutics Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Evaluating Ublituximab Monotherapy for the Treatment of Patients with Multiple Sclerosis
December 10, 2020
 · 
8 min read
Pharm Country
TG Therapeutics Announces Pivotal Data from the UNITY-CLL and UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual Meeting
December 7, 2020
 · 
9 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS